We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Nanofluidic Diffraction Grating Technique for DNA Amplification May Replace PCR

By LabMedica International staff writers
Posted on 21 Sep 2016
Print article
Image: A photo and a schematic illustration for a nanofluidic diffraction grating. Label-free signals based on a diffraction intensity change were attributed to amplification of DNA molecules, such as human papillomavirus and tubercle bacilli (Photo courtesy of Takao Yasui, Nagoya University).
Image: A photo and a schematic illustration for a nanofluidic diffraction grating. Label-free signals based on a diffraction intensity change were attributed to amplification of DNA molecules, such as human papillomavirus and tubercle bacilli (Photo courtesy of Takao Yasui, Nagoya University).
A team of Japanese biophysicists suggests replacing the RT-PCR (real time polymerase chain reaction) technique with a rapid label-free detection method for real-time DNA amplification using a nanofluidic diffraction grating.

Investigators at Nagoya University (Japan) based their strategy for quantifying DNA amplification in a label-free manner on observations of intensity changes of diffracted light derived from the passage of a laser beam through nanochannels embedded in a microchannel; the ability to diffract the beam is a basic characteristic of nanochannels.

In practice, they fabricated 2.7 micron deep, 200 nanometer wide periodic nanochannels embedded in microchannels, which were etched on fused silica substrates by electron beam lithography, photolithography, and plasma etching. For an incident laser beam they used a modulated 532 nanometer laser to amplify a specific component extracted from random or background noise.

They investigators reported in the August 17, 2016, online edition of the journal Scientific Reports that numerical simulations revealed that the diffracted light intensity change in the nanofluidic diffraction grating was attributed to the change of refractive index. Using the technique, they demonstrated the first case reported to date for label-free detection of real-time DNA amplification, such as specific DNA sequences from tubercle bacilli (TB) and human papillomavirus (HPV). Since the system allowed quantification of the initial concentration of amplified DNA molecules ranging from one femtomolar to one picomolar, the investigators expect that it will offer a new strategy for developing fundamental techniques of medical applications.

"Our system also measures DNA amplification at the relatively low temperature of 34 degrees Celsius and without the need for thermal cycles," said contributing author Dr. Noritada Kaji, associate professor of engineering at Nagoya University. "Because it has the potential to be constructed as a single chip and can detect sample volumes as small as one microliter, which is 100-1,000 times less than conventional detectors are capable of, it is particularly suited to development as a miniaturized form of diagnostics and microbe detection."

Related Links:
Nagoya University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.